Laure Elens

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Laure Elens, Rachida Bouamar, Dennis A. Hesselink et al. · Clinical Chemistry · 2011 · 240 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

Vincent Haufroid, Pierre Wallemacq, V. VanKerckhove et al. · American Journal of Transplantation · 2006 · 181 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of a New Functional<i>CYP3A4</i>Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients

Laure Elens, Ron HN van Schaik, Nadtha Panin et al. · Pharmacogenomics · 2011 · 152 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study

Laure Elens, Matthijs L. Becker, Vincent Haufroid et al. · Pharmacogenetics and Genomics · 2011 · 114 citations

Medicine, Molecular Genetics, Pharmacology +16

<i>CYP3A5</i> and <i>ABCB1</i> Polymorphisms Influence Tacrolimus Concentrations in Peripheral Blood Mononuclear Cells After Renal Transplantation

Arnaud Capron, Michel Mourad, Martine De Meyer et al. · Pharmacogenomics · 2010 · 109 citations

Medicine, Genetics, Pharmacokinetics +17